The clearance of apoptotic cells by complement

Immunobiology

Volumn 212, Issue 4-5, 2007, Pages 363-370

  Flierman, Roelof ^a   Daha, Mohamed R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Complement; Systemic lupus erythematosus

Indexed keywords

COLLECTIN; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; PENTRAXIN;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CLEARANCE; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; MATERIALS HANDLING; NONHUMAN; OPSONIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 34249697078     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2006.11.005     Document Type: Article

References (63)

1. Baruah P., Dumitriu I.E., Peri G., Russo V., Mantovani A., Manfredi A.A., and Rovere-Querini P. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J. Leukoc. Biol. 80 (2006) 87-95
2. Bickerstaff M.C., Botto M., Hutchinson W.L., Herbert J., Tennent G.A., Bybee A., Mitchell D.A., Cook H.T., Butler P.J., Walport M.J., and Pepys M.B. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5 (1999) 694-697
3. Bijl M., Horst G., Bijzet J., Bootsma H., Limburg P.C., and Kallenberg C.G. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages. Arthritis Rheum. 48 (2003) 248-254
4. Boes M., Schmidt T., Linkemann K., Beaudette B.C., Marshak-Rothstein A., and Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97 (2000) 1184-1189
5. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., and Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19 (1998) 56-59
6. Bruns A., Blass S., Hausdorf G., Burmester G.R., and Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum. 43 (2000) 2307-2315
7. Burlingame R.W., Boey M.L., Starkebaum G., and Rubin R.L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94 (1994) 184-192
8. Castellano G., Woltman A.M., Nauta A.J., Roos A., Trouw L.A., Seelen M.A., Schena F.P., Daha M.R., and van Kooten C. Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood 103 (2004) 3813-3820
9. Chang M.K., Binder C.J., Torzewski M., and Witztum J.L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc. Natl. Acad. Sci. USA 99 (2002) 13043-13048
10. Chen Z., Koralov S.B., and Kelsoe G. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 192 (2000) 1339-1352
11. Cole D.S., Hughes T.R., Gasque P., and Morgan B.P. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis. Mol. Immunol. 43 (2006) 1953-1964
12. Ehrenstein M.R., Cook H.T., and Neuberger M.S. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J. Exp. Med. 191 (2000) 1253-1258
13. Einav S., Pozdnyakova O.O., Ma M., and Carroll M.C. Complement C4 is protective for lupus disease independent of C3. J. Immunol. 168 (2002) 1036-1041
14. Elward K., Griffiths M., Mizuno M., Harris C.L., Neal J.W., Morgan B.P., and Gasque P. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 280 (2005) 36342-36354
15. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 (1998) 890-898
16. Familian A., Zwart B., Huisman H.G., Rensink I., Roem D., Hordijk P.L., Aarden L.A., and Hack C.E. Chromatin-independent binding of serum amyloid P component to apoptotic cells. J. Immunol. 167 (2001) 647-654
17. Flierman R., and Daha M.R. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis-a hypothesis. Mol. Immunol. 44 (2007) 133-138
18. Gallucci S., Lolkema M., and Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5 (1999) 1249-1255
19. Gasque P. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41 (2004) 1089-1098
20. Gershov D., Kim S., Brot N., and Elkon K.B. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192 (2000) 1353-1364
21. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., and Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417 (2002) 182-187
22. Hanayama R., Tanaka M., Miyasaka K., Aozasa K., Koike M., Uchiyama Y., and Nagata S. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304 (2004) 1147-1150
23. Hu D.E., Moore A.M., Thomsen L.L., and Brindle K.M. Uric acid promotes tumor immune rejection. Cancer Res. 64 (2004) 5059-5062
24. Huynh M.L., Fadok V.A., and Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109 (2002) 41-50
25. Jensen M.L., Honore C., Hummelshoj T., Hansen B.E., Madsen H.O., and Garred P. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol. Immunol. 44 (2007) 856-865
26. Jones J., and Morgan B.P. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. Immunology 86 (1995) 651-660
27. Kishore U., Gaboriaud C., Waters P., Shrive A.K., Greenhough T.J., Reid K.B., Sim R.B., and Arlaud G.J. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol. 25 (2004) 551-561
28. Kishore U., Greenhough T.J., Waters P., Shrive A.K., Ghai R., Kamran M.F., Bernal A.L., Reid K.B., Madan T., and Chakraborty T. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol. Immunol. 43 (2006) 1293-1315
29. Korb L.C., and Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158 (1997) 4525-4528
30. Liu K., Iyoda T., Saternus M., Kimura Y., Inaba K., and Steinman R.M. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196 (2002) 1091-1097
31. Marth T., and Kelsall B.L. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185 (1997) 1987-1995
32. McGrath F.D., Brouwer M.C., Arlaud G.J., Daha M.R., Hack C.E., and Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J. Immunol. 176 (2006) 2950-2957
33. Mevorach D., Mascarenhas J.O., Gershov D., and Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188 (1998) 2313-2320
34. Mohan C., Adams S., Stanik V., and Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177 (1993) 1367-1381
35. Morelli A.E., Larregina A.T., Shufesky W.J., Zahorchak A.F., Logar A.J., Papworth G.D., Wang Z., Watkins S.C., Falo Jr. L.D., and Thomson A.W. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101 (2003) 611-620
36. Nauta A.J., Trouw L.A., Daha M.R., Tijsma O., Nieuwland R., Schwaeble W.J., Gingras A.R., Mantovani A., Hack E.C., and Roos A. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 32 (2002) 1726-1736
37. Nauta A.J., Raaschou-Jensen N., Roos A., Daha M.R., Madsen H.O., Borrias-Essers M.C., Ryder L.P., Koch C., and Garred P. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur. J. Immunol. 33 (2003) 2853-2863
38. Nauta A.J., Bottazzi B., Mantovani A., Salvatori G., Kishore U., Schwaeble W.J., Gingras A.R., Tzima S., Vivanco F., Egido J., Tijsma O., Hack E.C., Daha M.R., and Roos A. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur. J. Immunol. 33 (2003) 465-473
39. Nauta A.J., Castellano G., Xu W., Woltman A.M., Borrias M.C., Daha M.R., van Kooten C., and Roos A. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J. Immunol. 173 (2004) 3044-3050
40. Nauta A.J., Roos A., and Daha M.R. A regulatory role for complement in innate immunity and autoimmunity. Int. Arch. Allergy Immunol. 134 (2004) 310-323
41. Navratil J.S., Watkins S.C., Wisnieski J.J., and Ahearn J.M. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J. Immunol. 166 (2001) 3231-3239
42. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., and Henson P.M. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194 (2001) 781-795
43. Païdassi H., Tacnet-Delorme P., Ghebrehiwet B., Arlaud G.J., and Frachet P. Phosphatidylserine is one of the C1q ligands on the surface of apoptotic cells. Mol. Immunol. 43 (2006) 136
44. Païdassi H., Tacnet-Delorme P., Garlatti V., Darnault C., Ghebrehiwet B., Gaboriaud C., Arlaud G.J., and Frachet P. C1q binds phosphatidylserine and likely acts as an early bridging molecule in apoptotic cell recognition and clearance. Mol. Immunol. 44 (2007) 225-226
45. Palaniyar N., Nadesalingam J., Clark H., Shih M.J., Dodds A.W., and Reid K.B. Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin. J. Biol. Chem. 279 (2004) 32728-32736
46. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., and Walport M.J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76 (2000) 227-324
47. Quartier P., Potter P.K., Ehrenstein M.R., Walport M.J., and Botto M. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur. J. Immunol. 35 (2005) 252-260
48. Roos A., Xu W., Castellano G., Nauta A.J., Garred P., Daha M.R., and van Kooten C. Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur. J. Immunol. 34 (2004) 921-929
49. Rovere P., Peri G., Fazzini F., Bottazzi B., Doni A., Bondanza A., Zimmermann V.S., Garlanda C., Fascio U., Sabbadini M.G., Rugarli C., Mantovani A., and Manfredi A.A. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 96 (2000) 4300-4306
50. Savill J., and Fadok V. Corpse clearance defines the meaning of cell death. Nature 407 (2000) 784-788
51. Schagat T.L., Wofford J.A., and Wright J.R. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J. Immunol. 166 (2001) 2727-2733
52. Sekine H., Reilly C.M., Molano I.D., Garnier G., Circolo A., Ruiz P., Holers V.M., Boackle S.A., and Gilkeson G.S. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J. Immunol. 166 (2001) 6444-6451
53. Shi Y., Evans J.E., and Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 (2003) 516-521
54. Shi Y., Galusha S.A., and Rock K.L. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8T lymphocytes to transplanted cells and in an autoimmune diabetes model. J. Immunol. 176 (2006) 3905-3908
55. Stuart L.M., Takahashi K., Shi L., Savill J., and Ezekowitz R.A. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J. Immunol. 174 (2005) 3220-3226
56. Takizawa F., Tsuji S., and Nagasawa S. Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells. FEBS Lett. 397 (1996) 269-272
57. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., and Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192 (2000) 359-366
58. Trouw L.A., Nilsson S.C., Goncalves I., Landberg G., and Blom A.M. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 201 (2005) 1937-1948
59. van Rossum A.P., Fazzini F., Limburg P.C., Manfredi A.A., Rovere-Querini P., Mantovani A., and Kallenberg C.G. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheum. 50 (2004) 2667-2674
60. Vandivier R.W., Ogden C.A., Fadok V.A., Hoffmann P.R., Brown K.K., Botto M., Walport M.J., Fisher J.H., Henson P.M., and Greene K.E. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169 (2002) 3978-3986
61. Verbovetski I., Bychkov H., Trahtemberg U., Shapira I., Hareuveni M., Ben Tal O., Kutikov I., Gill O., and Mevorach D. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 196 (2002) 1553-1561
62. Voll R.E., Roth E.A., Girkontaite I., Fehr H., Herrmann M., Lorenz H.M., and Kalden J.R. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 40 (1997) 2162-2171
63. Walport M.J. Complement and systemic lupus erythematosus. Arthritis Res. 4 Suppl 3 (2002) S279-S293